ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1866

Identification of Sjögren’s Disease-Associated CD4+ T Cell Receptor (TCR) Motifs and Repertoire Landscape Through TCR Deep Sequencing

Ananth Aditya Jupudi1, Michelle L. Joachims2, Christina Lawrence2, Charmaine Lopez-Davis2, Bhuwan Khatri2, Astrid Rasmussen2, Kiely Grundahl2, Robert Hal Scofield2, Judith James2, Joel Guthridge2, Christopher Lessard2, Linda F. Thompson2 and A. Darise Farris2, 1University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: ACR Convergence 2024

Keywords: autoantigens, Sjögren's syndrome, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Sjögren’s disease (SjD) is a chronic rheumatic autoimmune disorder characterized by focal lymphocytic infiltration of the lacrimal and salivary glands (SG). CD4+ T cells dominate the foci and play a pivotal role in pathogenesis, as suggested by association of SjD with the HLA DR3/DQ2 haplotype. Here, our objectives are to conduct deep profiling of the peripheral blood (PB) TCR repertoire of SjD cases and HCs, identify disease-associated TCR motifs, and determine whether TCRs expressed on clonally expanded SG-derived CD4+ T cells are enriched in the peripheral blood (PB) of SjD cases compared to HCs.    

Methods: PB samples were collected from 19 SjD cases (16 DR3+DQ2+, 2 DR3–/DQ2–, 1 DR3+DQ2–) meeting the 2016 ACR/EULAR SjD classification criteria and 19 DR3+DQ2+ HCs matched for age, sex, and race. CD3+CD4+CD45RA– T-cells were bulk-sorted followed by RNA extraction, cDNA synthesis, and generation of TCRβ libraries for deep sequencing1. CDR3β sequences, VDJ gene usage, and clonotype information was retrieved from sequencing data. Paired a/b SG TCR sequences were also extracted from the SjD patients (n=10 by TCR RT-PCR2, n=9 by single-cell RNAseq) and included for CDR3β motif analysis. Disease-associated TCR clusters with putative shared antigen specificity were identified using the ‘GLIPH2’ algorithm3. Generation probability(pGen) scores of CDR3β amino acid sequences were calculated using OLGA software.

Results: We analyzed 1743 paired SG-CDR3 a/b sequences from cases and 2,953,511 PB-CDR3β sequences from cases and HC. For all cases with ≥50 sampled SG-T cells (n = 10), identical TCR-CDR3β expressed on clonally expanded SG-T cells were detected in the PB of the same patient. GLIPH2 TCR clusters including SG-clonal expansions (n = 31), Vb gene-enrichment and conserved CDR3 length (n = 14), were exclusively shared between the SG and PB TCR repertoires of cases and not HC. Thirteen TCR clusters shared between the two tissues were more abundant in the blood of cases vs. HC (p < 0.05, Mann Whitney U test). Such ‘shared’ clusters were detected in all 10 cases above, and the number of such clusters was inversely associated with whole unstimulated salivary flow (Spearman r = -0.7317, p = 0.02). SjD cases exhibited restricted PB-TCRβ usage, reduced TCR diversity, and higher abundance of clonotypes compared to HC (p < 0.05, Mann Whitney U test). PB-CDR3β sequences detected in cases were more ‘private’ with increasing average frequency when compared to the ‘shared’ public nature of the HC repertoire (p < 2 x 10-16, pGen vs. average frequency generalized linear regression model).

Conclusion: This is the first study showing that SjD-associated TCRs enriched in clonally-expanded CD4+ T-cells of SG tissue are also abundant in the blood of the same patient. The presence of T cell clones with similar antigen specificity shared across SG and blood of multiple patients suggests that a common set of antigens may trigger pathogenic CD4+ T cells in SjD.

1. Mamedov, et al. Front Immunol. 2013, PMID: 24391640

2. Joachims, et al. J. Clin. Med. 2020, PMID: 32650575

3. Huang,et al. Nat Biotechnol. 2020, PMID: 32341563


Disclosures: A. Jupudi: None; M. Joachims: None; C. Lawrence: None; C. Lopez-Davis: None; B. Khatri: None; A. Rasmussen: None; K. Grundahl: None; R. Scofield: Johnson and Johnson Innovative Medicine, 1, Merck, 1; J. James: GlaxoSmithKlein(GSK), 1, Progentec Diagnostics, Inc., 5, 10; J. Guthridge: AstraZeneca, 5, Bristol-Myers Squibb(BMS), 5; C. Lessard: Johnson and Johnson Innovative Medicine, 2, 5, Johnson and Johnson Sjögren's Disease Advisory Board, 1; L. Thompson: None; A. Farris: Johnson and Johnson Innovative Medicine, 5.

To cite this abstract in AMA style:

Jupudi A, Joachims M, Lawrence C, Lopez-Davis C, Khatri B, Rasmussen A, Grundahl K, Scofield R, James J, Guthridge J, Lessard C, Thompson L, Farris A. Identification of Sjögren’s Disease-Associated CD4+ T Cell Receptor (TCR) Motifs and Repertoire Landscape Through TCR Deep Sequencing [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/identification-of-sjogrens-disease-associated-cd4-t-cell-receptor-tcr-motifs-and-repertoire-landscape-through-tcr-deep-sequencing/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-sjogrens-disease-associated-cd4-t-cell-receptor-tcr-motifs-and-repertoire-landscape-through-tcr-deep-sequencing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology